OCI completes sale of methanol business to Methanex for $1.6 billion

Published 27/06/2025, 15:38
OCI completes sale of methanol business to Methanex for $1.6 billion

AMSTERDAM - OCI Global (Euronext:OCI), whose stock has surged over 57% in the past year and maintains a "GOOD" overall financial health score according to InvestingPro, has completed the sale of its Global Methanol Business to Methanex Corporation (TSX:MX) (Nasdaq:MEOH) for $1.6 billion, the company announced Friday.

The transaction, first announced in September 2024, includes approximately $1.3 billion in cash and 9.9 million Methanex shares valued at $346 million. The deal gives OCI a 12.9% stake in Methanex, making it the second-largest shareholder in the company.

OCI plans to launch a tender offer for its $600 million 6.700% Notes due 2033 within five business days of the closing, offering 110.75% of par value plus accrued interest.

The company also announced plans to return up to $1 billion to shareholders through 2025 and early 2026. The first tranche of approximately $700 million is expected to be paid by September 5, 2025, through capital repayments and cash dividends.

"Including the proposed $1 billion distribution, we will have returned over $7.4 billion to shareholders since 2021," said Nassef Sawiris, Executive Chairman of OCI.

The divested methanol business includes facilities in Beaumont, Texas, with production capacity of 910,000 tonnes of methanol and 340,000 tonnes of ammonia, a 50% interest in Natgasoline joint venture, and a currently inactive facility in Delfzijl, Netherlands. The business also includes OCI HyFuels, which produces low-carbon methanol.

Morgan Stanley & Co. International served as financial advisor to OCI on the transaction, according to the company’s press release statement.

In other recent news, OCI NV has been actively engaging in strategic changes and financial adjustments. The company announced four major divestments totaling $11.6 billion, with approximately $4.4 billion returned to shareholders. OCI plans further capital distribution of up to $1 billion, contingent on the sale of its Methanol business to Methanex, expected in the first half of 2025. Moody’s Ratings downgraded OCI’s long-term corporate family rating to Ba2, citing a weakened business profile and unclear strategic direction. The company’s credit rating remains under review for potential further downgrades. Berenberg analysts downgraded OCI’s stock from Buy to Hold, with a revised price target of €8.70. Similarly, Citi analysts downgraded OCI from Buy to Neutral, lowering the price target to €8.30, following a significant shareholder return. These developments reflect a cautious outlook on OCI’s stock, despite the company’s substantial net cash position and liquidity.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.